Fold Holdings, Inc. Class A Common Stock (FLD)vsNomura Holdings Inc ADR (NMR)
FLD
Fold Holdings, Inc. Class A Common Stock
$0.54
+3.73%
FINANCIAL SERVICES · Cap: $25.46M
NMR
Nomura Holdings Inc ADR
$10.86
+3.04%
FINANCIAL SERVICES · Cap: $31.13B
Smart Verdict
WallStSmart Research — data-driven comparison
Nomura Holdings Inc ADR generates 8262710% more annual revenue ($2.33T vs $28.21M). NMR leads profitability with a 17.3% profit margin vs -258.6%. NMR earns a higher WallStSmart Score of 84/100 (A-).
FLD
Hold38
out of 100
Grade: F
NMR
Exceptional Buy84
out of 100
Grade: A-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 1622.0% YoY
Reasonable price relative to book value
Strong operational efficiency at 30.8%
Revenue surging 31.2% year-over-year
Growing faster than its price suggests
Attractively priced relative to earnings
Earnings expanding 42.0% YoY
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -137.2% — below average capital efficiency
Revenue declined 25.5%
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : FLD
The strongest argument for FLD centers on Price/Book, EPS Growth.
Bull Case : NMR
The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.
Bear Case : FLD
The primary concerns for FLD are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : NMR
The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.
Key Dynamics to Monitor
FLD profiles as a turnaround stock while NMR is a growth play — different risk/reward profiles.
NMR carries more volatility with a beta of 0.61 — expect wider price swings.
NMR is growing revenue faster at 31.2% — sustainability is the question.
Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NMR scores higher overall (84/100 vs 38/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fold Holdings, Inc. Class A Common Stock
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Fold Holdings, Inc. (FLD) is an innovative biotechnology firm dedicated to the development of groundbreaking therapies for severe genetic and rare diseases, utilizing advanced research methodologies and proprietary technologies. With a promising product pipeline bolstered by strategic collaborations, the company is poised to capitalize on substantial market opportunities within the healthcare sector. Fold's steadfast focus on scientific excellence and patient-centered solutions underscores its potential as a significant investment prospect, offering the promise of long-term growth and enhanced shareholder value in an evolving industry landscape.
Visit Website →Nomura Holdings Inc ADR
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.
Compare with Other CAPITAL MARKETS Stocks
Want to dig deeper into these stocks?